DTL
ADVM

Dynamic Technology Lab’s Adverum Biotechnologies ADVM Stock Holding History

Dynamic Technology Lab’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,537
Closed -$54K – 1021
2021
Q2 		$54K Buy
+1,537
New +$82.8K 0.01% 1063
2021
Q1 		– Sell
-2,699
Closed -$293K – 1099
2020
Q4 		$293K Buy
+2,699
New +$334K 0.05% 673
2018
Q4 		– Sell
-2,556
Closed -$155K – 944
2018
Q3 		$155K Buy
+2,556
New +$144K 0.02% 922
2018
Q1 		– Sell
-1,033
Closed -$36K – 1004
2017
Q4 		$36K Buy
+1,033
New +$34K 0.01% 963

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's ADVM Position: Q3 2021 in Review

Dynamic Technology Lab sold out of Adverum Biotechnologies (ADVM) in Q3 2021, closing a stake of 1,537 shares — an estimated $54K sold.

Dynamic Technology Lab first reported a position in ADVM in Q4 2017 and held it in 4 quarters. The position peaked at $293K in Q4 2020. 110 funds tracked by Wall St. Rank hold ADVM as of Q3 2021.

  • Dynamic Technology Lab reported no remaining Adverum Biotechnologies position as of Q3 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,537 Adverum Biotechnologies shares in Q3 2021, an estimated $54K.
  • Dynamic Technology Lab first reported a position in Adverum Biotechnologies in Q4 2017 and held it in 4 quarters.
  • Dynamic Technology Lab's Adverum Biotechnologies position peaked at $293K in Q4 2020.
  • 110 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2021.

Based on Dynamic Technology Lab's 13F filing for Q3 2021, filed 15 Nov 2021.